Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -63.06% is 43% above its 5-year average of -111.29%, near the high end of its 5-year range (-174.96%–-56.85%).
1.03% below its 12-month average of -62.42%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -56.85%.
NET PROFIT MARGIN
-63.06%
NET PROFIT MARGIN AVG TTM
-62.42%
NET PROFIT MARGIN AVG 3Y
-96.28%
NET PROFIT MARGIN AVG 5Y
-111.29%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.03%
CURRENT VS 3Y AVG
+34.50%
CURRENT VS 5Y AVG
+43.34%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 720 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Outset Medical, Inc.
Market Cap
$76.35M
Net Profit Margin
-63.06%
TTM Avg
-62.42%
3Y Avg
-96.28%
5Y Avg
-111.29%
Market Cap
$75.81M
Net Profit Margin
-210.75%
TTM Avg
-289.10%
3Y Avg
-513.23%
5Y Avg
-2388.54%
Market Cap
$77.54M
Net Profit Margin
-155404.38%
TTM Avg
-155404.38%
3Y Avg
-155404.38%
5Y Avg
-155404.38%
Market Cap
$73.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-13227.36%
5Y Avg
-12286.00%
Market Cap
$79.46M
Net Profit Margin
-130000.00%
TTM Avg
-89627.13%
3Y Avg
-49555.20%
5Y Avg
-36262.68%
Market Cap
$79.83M
Net Profit Margin
-55.03%
TTM Avg
-63.48%
3Y Avg
-81.34%
5Y Avg
-87.39%
Market Cap
$81.38M
Net Profit Margin
-430.43%
TTM Avg
-446.97%
3Y Avg
-347.08%
5Y Avg
-386.84%
Market Cap
$82.45M
Net Profit Margin
-1168.20%
TTM Avg
-1464.39%
3Y Avg
-946.48%
5Y Avg
-672.82%
Market Cap
$70.25M
Net Profit Margin
-105.29%
TTM Avg
-106.48%
3Y Avg
-112.00%
5Y Avg
-95.88%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outset Medical, Inc. (OM) | $76.35M | -63.06% | -62.42% | -96.28% | -111.29% |
| Hyperfine, Inc. (HYPR)vs › | $75.81M | -210.75% | -289.10% | -513.23% | -2388.54% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | -155404.38% | -155404.38% | -155404.38% | -155404.38% |
| Gain Therapeutics, Inc. (GANX)vs › | $73.88M | 0.00% | 0.00% | -13227.36% | -12286.00% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | -130000.00% | -89627.13% | -49555.20% | -36262.68% |
| Pulmonx Corporation (LUNG)vs › | $79.83M | -55.03% | -63.48% | -81.34% | -87.39% |
| Nutriband Inc. (NTRB)vs › | $81.38M | -430.43% | -446.97% | -347.08% | -386.84% |
| MediciNova, Inc. (MNOV)vs › | $82.45M | -1168.20% | -1464.39% | -946.48% | -672.82% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.25M | -105.29% | -106.48% | -112.00% | -95.88% |
| LENSAR Inc (LNSR)vs › | $82.53M | 57.57% | -58.69% | -51.95% | -56.60% |
Operating Margin
-56.1%
Net Profit Margin
-63.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -56.85% |
| 2026-03-31 | -68.11% |
| 2025-12-31 | -67.50% |
| 2025-09-30 | -60.61% |
| 2025-06-30 | -59.01% |
| 2025-03-31 | -86.66% |
| 2024-12-31 | -87.01% |
| 2024-09-30 | -97.47% |
| 2024-06-30 | -125.80% |
| 2024-03-31 | -141.81% |
| 2023-12-31 | -126.53% |
| 2023-09-30 | -152.10% |
| 2023-06-30 | -122.21% |
| 2023-03-31 | -131.39% |
| 2022-12-31 | -129.48% |
| 2022-09-30 | -146.90% |
| 2022-06-30 | -174.96% |
| 2022-03-31 | -120.76% |
| 2021-12-31 | -146.46% |
| 2021-09-30 | -115.78% |
| 2021-06-30 | -119.80% |
| 2021-03-31 | -131.02% |
| 2020-12-31 | -185.79% |
| 2020-09-30 | -307.46% |
| 2020-06-30 | -225.73% |
| 2020-03-31 | -287.20% |
| 2019-12-31 | -274.47% |
| 2019-09-30 | -585.63% |
| 2019-06-30 | -872.46% |
| 2019-03-31 | -975.19% |
